CLINICAL_TRIALS
trial_result
· 2024-05-21
Clinical Trial Update: Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau [Phase 2]
Summary
A Phase 2 trial assessing contrast-enhanced ultrasound for screening kidney cancer in patients with Von Hippel-Lindau disease has completed, with results posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Von-Hippel Lindau, Kidney Disease, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2024-05-21